FDA Issues Warning on Kratom

Last updated:

The FDA issued a public health advisory concerning the risks associated with the use of kratom. The plant, which grows in Thailand, Malaysia, Indonesia and Papua New Guinea, is being turned into medical and recreational products that are increasingly being imported into the US. Kratom is used to treat serious medical conditions such as pain, anxiety and depression, and it is also used recreationally. The FDA likens it to opioids, in that it can be abused and lead to addiction.

There have been 36 deaths tied to the use of kratom, as well as serious side effects like seizures, liver damage and withdrawal symptoms. Kratom, which has been banned in 16 countries and 5 US states, has been labeled “unapproved” by the agency.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Recommend More Articles Like This?

Show Comments (0)
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x